M. R. Jordan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M. R. Jordan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
A. Calmy
17Médecins sans Frontière Access Campaign, Geneva
1 shared publicationA. M. Wensing
10University Medical Center Utrecht, the Netherlands
1 shared publicationA. Phillips
14University College London, United Kingdom
1 shared publication- Andrea De Luca
Division of Infectious Diseases, Siena University Hospital, Siena, Italy
1 shared publication C. M. McClure
World Health Organization, Geneva, Switzerland
1 shared publicationC. P. Archibald
19Public Health Agency of Canada, Ottawa
1 shared publication
Latest Publications
- Open Access
- 27 April 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl 4) , S245-S249
Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011
The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.
- 27 April 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl 4) , S245-S249
Open AccessUpdate on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011
The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.